Search research articles
Contact Us
Filters
Showing results (11-20 of 95) with videos related to
Page
of 10
Sort By:
Seminars in Oncology
|
May 23, 2002
Pemetrexed for diffuse malignant pleural mesothelioma
Christian Manegold, Joseph Aisner
Lung Cancer (Amsterdam, Netherlands)
|
July 21, 2004
Chemotherapy for malignant pleural mesothelioma: past results and recent developments
Sandra Tomek, Christian Manegold
Translational Lung Cancer Research
|
March 26, 2015
Chemotherapy of lung cancer: A global perspective of the role of ifosfamide
Caicun Zhou, Christian Manegold
Lung Cancer (Amsterdam, Netherlands)
|
October 11, 2007
Survival improvement in thoracic cancer: progress from the last decade and beyond
Christian Manegold, Nicholas Thatcher
Lung Cancer (Amsterdam, Netherlands)
|
October 11, 2007
Achieving survival improvement in thoracic tumours: from therapeutic strategy management to pharmacogenomics
Nicholas Thatcher, Christian Manegold
Lung Cancer (Amsterdam, Netherlands)
|
July 18, 2003
Advanced NSCLC: new cytostatic agents
Paris A Kosmidis, Christian Manegold
Seminars in Oncology
|
February 1, 2017
Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: An international update
Mark G Kris, Christian Manegold
Translational Lung Cancer Research
|
March 26, 2015
Something in need is something indeed
Caicun Zhou, Christian Manegold, Yong Song
Translational Lung Cancer Research
|
March 26, 2015
Targeting angiogenesis in lung cancer - Pitfalls in drug development
Wolfgang Hilbe, Christian Manegold, Andreas Pircher
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2012
Design of clinical studies: adaptive randomization and progression-free survival (PFS) as an endpoint in clinical studies of advanced non-small cell lung cancer (NSCLC)
Daniel Schrimpf, Christian Manegold, Lothar R Pilz
Page
of 10
Search research articles
Search
Showing results (11-20 of 95) with videos related to
Sort By:
Page
of 10
Seminars in Oncology
|
May 23, 2002
Pemetrexed for diffuse malignant pleural mesothelioma
Christian Manegold, Joseph Aisner
Lung Cancer (Amsterdam, Netherlands)
|
July 21, 2004
Chemotherapy for malignant pleural mesothelioma: past results and recent developments
Sandra Tomek, Christian Manegold
Translational Lung Cancer Research
|
March 26, 2015
Chemotherapy of lung cancer: A global perspective of the role of ifosfamide
Caicun Zhou, Christian Manegold
Lung Cancer (Amsterdam, Netherlands)
|
October 11, 2007
Survival improvement in thoracic cancer: progress from the last decade and beyond
Christian Manegold, Nicholas Thatcher
Lung Cancer (Amsterdam, Netherlands)
|
October 11, 2007
Achieving survival improvement in thoracic tumours: from therapeutic strategy management to pharmacogenomics
Nicholas Thatcher, Christian Manegold
Lung Cancer (Amsterdam, Netherlands)
|
July 18, 2003
Advanced NSCLC: new cytostatic agents
Paris A Kosmidis, Christian Manegold
Seminars in Oncology
|
February 1, 2017
Docetaxel (Taxotere) in the treatment of non-small cell lung cancer: An international update
Mark G Kris, Christian Manegold
Translational Lung Cancer Research
|
March 26, 2015
Something in need is something indeed
Caicun Zhou, Christian Manegold, Yong Song
Translational Lung Cancer Research
|
March 26, 2015
Targeting angiogenesis in lung cancer - Pitfalls in drug development
Wolfgang Hilbe, Christian Manegold, Andreas Pircher
International Journal of Clinical Pharmacology and Therapeutics
|
December 25, 2012
Design of clinical studies: adaptive randomization and progression-free survival (PFS) as an endpoint in clinical studies of advanced non-small cell lung cancer (NSCLC)
Daniel Schrimpf, Christian Manegold, Lothar R Pilz
Page
of 10